Decay-accelerating factor modulates induction of T cell immunity
Top Cited Papers
Open Access
- 9 May 2005
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 201 (10) , 1523-1530
- https://doi.org/10.1084/jem.20041967
Abstract
Decay-accelerating factor (Daf) dissociates C3/C5 convertases that assemble on host cells and thereby prevents complement activation on their surfaces. We demonstrate that during primary T cell activation, the absence of Daf on antigen-presenting cells (APCs) and on T cells enhances T cell proliferation and augments the induced frequency of effector cells. The effect is factor D- and, at least in part, C5-dependent, indicating that local alternative pathway activation is essential. We show that cognate T cell–APC interactions are accompanied by rapid production of alternative pathway components and down-regulation of Daf expression. The findings argue that local alternative pathway activation and surface Daf protein function respectively as a costimulator and a negative modulator of T cell immunity and explain previously reported observations linking complement to T cell function. The results could have broad therapeutic implications for disorders in which T cell immunity is important.Keywords
This publication has 28 references indexed in Scilit:
- CD8 T Cells Can Reject Major Histocompatibility Complex Class I-Deficient Skin AllograftsAmerican Journal of Transplantation, 2004
- Local synthesis of complement component C3 regulates acute renal transplant rejectionNature Medicine, 2002
- Effector and memory T-cell differentiation: implications for vaccine developmentNature Reviews Immunology, 2002
- Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infectionNature Medicine, 2002
- GPI-microdomains: a role in signalling via immunoreceptorsImmunology Today, 1999
- A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells.International Immunology, 1998
- THE MALE-SPECIFIC HISTOCOMPATIBILITY ANTIGEN, H-Y:A History of Transplantation, Immune Response Genes, Sex Determination and Expression CloningAnnual Review of Immunology, 1997
- Noncovalent associations of T lymphocyte surface proteinsEuropean Journal of Immunology, 1996
- The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF).The Journal of Experimental Medicine, 1996
- Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.The Journal of Experimental Medicine, 1984